Sensus Healthcare, Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Sensus Healthcare, Inc. payments for repurchase of common stock for the quarter ending 2025-12-31 was $0.00.
- Sensus Healthcare, Inc. payments for repurchase of common stock for the quarter ending 2025-09-30 was $0.00.
- Sensus Healthcare, Inc. payments for repurchase of common stock for the quarter ending 2025-06-30 was $0.00.
- Sensus Healthcare, Inc. payments for repurchase of common stock for the quarter ending 2025-03-31 was $300.00K.
- Sensus Healthcare, Inc. payments for repurchase of common stock for fiscal 2025 was $300.00K.
- Sensus Healthcare, Inc. payments for repurchase of common stock for fiscal 2023 was $27.00K, a 99.10% decline from fiscal 2022.
- Sensus Healthcare, Inc. payments for repurchase of common stock for fiscal 2022 was $3.00M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $300.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | |
| 2025-03-31 | $300.00K 10-Q · filed 2026-05-13 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $27.00K 10-K · filed 2025-03-05 |
| 2022-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $3.00M 10-K · filed 2024-03-15 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |